Union européenne - français - EMA (European Medicines Agency)

viatris limited - bésilate de clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - agents antithrombotiques - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). Élévation du segment st infarctus aigu du myocarde, en association avec de l'aas dans traitée médicalement les patients éligibles à un traitement thrombolytique. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. pour de plus amples informations, veuillez vous reporter à la section 5.

Canada - français - Health Canada

auro pharma inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors

Canada - français - Health Canada

nora pharma inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors

Canada - français - Health Canada

nora pharma inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors

Canada - français - Health Canada

apotex inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors

Canada - français - Health Canada

marcan pharmaceuticals inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors

Canada - français - Health Canada

marcan pharmaceuticals inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors

Canada - français - Health Canada

marcan pharmaceuticals inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors

Canada - français - Health Canada

apotex inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors

Canada - français - Health Canada

marcan pharmaceuticals inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors